BIOHAVEN LTD (BHVN)

VGG1110E1079 - Common Stock

38.97  +0.43 (+1.12%)

After market: 38.74 -0.23 (-0.59%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to BHVN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 60.69. This target is 55.74% above the current price.
BHVN was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BHVN.
In the previous month the buy percentage consensus was at a similar level.
BHVN was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 38.9755.5560.1860.6969.30 - 42.55% 54.43% 55.74% 77.83%
Up and Down Grades
Date Firm Action Rating
2024-04-23 UBS Maintains Buy -> Buy
2024-04-18 Cantor Fitzgerald Reiterate Overweight
2024-04-10 Cantor Fitzgerald Reiterate Overweight
2024-04-09 RBC Capital Reiterate Outperform -> Outperform
2024-03-04 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-01 TD Cowen Maintains Outperform -> Outperform
2024-03-01 RBC Capital Maintains Outperform -> Outperform
2024-02-23 JP Morgan Maintains Overweight -> Overweight
2024-02-16 RBC Capital Initiate Outperform
2024-02-06 UBS Initiate Buy
2023-12-22 HC Wainwright & Co. Initiate Buy
2023-12-08 Baird Initiate Outperform
2023-11-20 JP Morgan Maintains Overweight -> Overweight
2023-11-15 Piper Sandler Maintains Overweight -> Overweight
2023-08-16 JP Morgan Maintains Overweight -> Overweight
2023-07-17 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-06-06 BTIG Reiterate Buy
2023-04-04 Cantor Fitzgerald Maintains Overweight
2023-01-24 SVB Leerink Initiate Outperform
2023-01-04 JP Morgan Initiate Overweight
2022-12-02 BTIG Initiate Buy
2022-10-26 Piper Sandler Maintains Overweight
2022-10-12 Piper Sandler Initiate Overweight
2022-08-19 Piper Sandler Downgrade Overweight -> Neutral
2022-08-08 Wedbush Downgrade Outperform -> Neutral
2022-05-11 SVB Leerink Downgrade Outperform -> Market Perform
2022-05-11 Morgan Stanley Maintains Equal-Weight
2022-05-11 HC Wainwright & Co. Downgrade Buy -> Neutral
2022-03-03 Mizuho Maintains Buy
2022-01-07 Morgan Stanley Maintains Equal-Weight